Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIAL
Nola M. Hylton(University of California, San Francisco), Mitchell D. Schnall(California University of Pennsylvania), Jeffrey D. Blume(Vanderbilt University), Sandra M. Polin(Washington Radiology Associates), Etta D. Pisano(SUNY Sullivan), Laura J. Esserman(University of California, San Francisco), Helga S. Marques(John Brown University), Constance D. Lehman(Harvard University), Gillian M. Newstead(University of Chicago), Mark Rosen(California University of Pennsylvania), Paul T. Weatherall, Wanda K. Bernreuter(University of Alabama), Elizabeth A. Morris(University of California Davis Medical Center)
Cited by 487
Related Papers
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
|CA A Cancer Journal for Clinicians|2007|2.6k
The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse
|Osteoarthritis and Cartilage|2007|1.5k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
|Journal of Clinical Oncology|2021|991